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ABSTRACT
A bioluminescent assay based on a system of coupled enzy-
matic reactions catalyzed by bacterial luciferase and NADH:
FMN-oxidoreductase was developed to monitor toxicity and
antioxidant activity of bioactive compounds. The assay
enables studying toxic effects at the level of biomolecules and
physicochemical processes, as well as determining the toxicity
of general and oxidative types. Toxic and detoxifying effects
of bioactive compounds were studied. Fullerenols, perspective
pharmaceutical agents, nanosized particles, water-soluble
polyhydroxylated fullerene-60 derivatives were chosen as
bioactive compounds. Two homologous fullerenols with dif-
ferent number and type of substituents, C60O2–4(OH)20–24
and Fe0.5C60(OH) xOy (x + y = 40–42), were used. They sup-
pressed bioluminescent intensity at concentrations
>0.01 g L1 and >0.001 g L1 for C60O2–4(OH)20-24 and
Fe0.5C60(OH)xOy, respectively; hence, a lower toxicity of
C60O2–4(OH)20–24 was demonstrated. Antioxidant activity of
fullerenols was studied in model solutions of organic and
inorganic oxidizers; changes in toxicities of general and
oxidative type were determined; detoxiﬁcation coefﬁcients
were calculated. Fullerenol C60O2–4(OH)20–24 revealed higher
antioxidant ability at concentrations 1017105 g L1. The
difference in the toxicity and antioxidant activity of fullere-
nols was explained through their electron donor/acceptor
properties and different catalytic activity. Principles of biolu-
minescent enzyme assay application for evaluating the toxic
effect and antioxidant activity of bioactive compounds were
summarized.
INTRODUCTION
Fullerenols are nanosized structures, water-soluble polyhydroxy-
lated derivatives of fullerenes (an allotropic form of carbon),
bioactive compounds and perspective pharmaceutical agents.
Chemical structure of a representative of fullerenol group,
C60(OH)x, is presented in Scheme 1.
Fullerenols are electron deﬁcient structures, and this property
makes them useful as efﬁcient catalyzers in biochemical reactions.
Fullerenols are amphiphilic structures: Hydroxyl groups provide
them with aqueous solubility, while the fragments of fullerene
skeleton—with afﬁnity to hydrophobic enzymatic fragments and
lipid structures of cellular membranes (1,2). The aqueous solubil-
ity of fullerenols depends on the amount of hydroxyl groups (3).
Being bioactive compounds, fullerenols can produce either
toxic or activating effect (3–6). The biological activity of a series
of fullerenols C60(OH)12–14, C60(OH)18–24, C60(OH)30–38 was
studied by Eropkin and coworkers (3). Fullerenols C60(OH)18–24
have revealed maximal biological activity (4,7,8). Fullerenols
demonstrated antioxidant activity, neutralizing reactive oxygen
and nitrogen species (5,8,9), correcting neurological diseases
(4,5,9,10), as well as functioning as radioprotectors (9) or antitu-
mor agents (6).
The bioluminescence assays based on luminous marine bacte-
ria or their enzymes are proper candidates for monitoring the
toxicity and antioxidant activity of fullerenols. Bioluminescence
of marine bacteria is known to be sensitive to toxic compounds;
this is why the bacteria have been widely used as a bioassay
for several decades (11–15). The physiological parameter being
tested here is luminescence intensity; it can be easily measured
instrumentally. Suppression of the bioluminescent intensity eval-
uates toxicity of aqueous solutions, while the bioluminescence
activation serves as an evidence of improving the luminescent
physiological function. The last decade has seen the application
of luminous bacteria to monitor biological effects of low-dose
ionizing radiation (16–18). Due to simplicity and high rates of
test procedure, bacteria-based bioluminescent assay makes it
possible to simultaneously analyze many test samples, and,
therefore, perform a proper statistical treatment of low-dose
effects.
Bacterial bioluminescent assays can be based on biological
systems of different complexity—bacteria or their enzymes,
providing comparison of toxic effects on microorganisms or
their enzymatic reactions (12,16–20). These assays allow for
studying the mechanisms of toxic effects at cellular or molecu-
lar levels, respectively. The possibility of studying the physico-
chemical and molecular mechanisms of toxic effects is a
beneﬁt of the enzymatic assay. The physicochemical classiﬁca-
tion of the effects of toxic compounds on bioluminescent
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enzyme system was suggested by Kudryasheva (21) and devel-
oped in (22–25).
Enzymatic bioassay can be used for evaluating both general
and oxidative toxicities of test samples. Oxidative toxicity is
attributed to redox activity of toxic compounds, while the gen-
eral toxicity (GT) integrates, in a nonadditive way, all the
interactions of toxic compounds with components of the biolu-
minescent enzymatic system, that is redox, hydrophobic and
polar interactions. Using the bioluminescent enzymatic assay,
the general and oxidative toxicities of organic and inorganic
oxidizer’ solutions, quinones and polyvalent metals, have been
previously studied (25–27). A decrease of both general and
oxidative toxicities under exposure to humic substances, the
products of natural decomposition of organic matter in soil
and bottom sediments, has been previously demonstrated
(28–30).
This study develops an application of the enzyme-based biolu-
minescent assay system for evaluating the toxicity and antioxi-
dant properties of bioactive compounds, fullerenols. A wide
range of fullerenol concentrations was tested. The toxicity and
detoxifying activities of two fullerenols differed in the number of
hydroxyl group and metal substituents, that is C60O2–4(OH)20–24
and Fe0.5C60(OH)xOy (x + y = 40–42), have been studied. Inor-
ganic and organic compounds with oxidative propensity (com-
plex salt potassium ferricyanide K3[Fe(CN)6] and 1,4-
benzoquinone) were used as model toxicants. Potassium ferri-
cyanide was chosen because of its stability in water solutions (in
contrast to unclustered iron salts) and monoelectron oxidative
transition Fe3+/Fe2+ (31). The 1,4-benzoquinone was chosen as
being a typical representative of the organic oxidizer group. In
nature, quinones can appear as a result of an oxidative transfor-
mation of various phenols (32,33), that is numerous group of
hydroxylated aromatic compounds. They are ranked third in the
top list of widespread pollutants (after metal salts and oil prod-
ucts) and are common components of industrial wastewaters.
The ability of quinones to deactivate the bacterial enzyme by dis-
lodging ﬂavin, coenzyme of bacterial luciferase, was demon-
strated previously in time-resolved ﬂuorescence experiments
(34).
The study evaluates fullerenol concentrations which produce a
toxic effect (section 3.16 ) and a decrease of general and oxidative
toxicities in solutions (section 3.2). The effects of two fullerenols
are compared: C60O2–4(OH)20–24 and Fe0.5C60(OH)xOy
(x + y = 40–42). The principles of bioluminescent enzyme assay
application for evaluating fullerenol’s toxic effect and antioxidant
activity are summarized in Conclusions.
MATERIALS AND METHODS
Reagents and equipment. Toxicity of water solutions of model oxidizers
K3[Fe(CN)6] (potassium ferricyanide) and 1,4-benzoquinone was assessed
using enzymatic assay, that is the preparation based on the coupled
enzyme system NADH:FMN-oxidoreductase from Vibrio ﬁscheri (0.15
a.u.) and luciferase from Photobacterium leiognathi, 0.5 mg mL1 (35).
The preparation was produced at the Institute of Biophysics SB RAS
(Krasnoyarsk, Russia). The chemicals used were as follows: NADH from
ICN; FMN and tetradecanal from SERVA, Germany; analytical grade
potassium ferricyanide, Khimreactiv, Russia; 1,4-benzoquinone, Aldrich.
The enzymatic assay system includes two coupled reactions: 7
NADHþFMNNADH : FMN-oxidoreductase
! FMN H
 þNADþ
ðreaction 1Þ
FMN HþRCHOþO2 luciferase
!FMNþRCOO
þH2Oþhm:
ðreaction 2Þ
To construct the enzyme system, 0.1 mg ml1 enzyme preparation,
5∙104 M FMN, 4∙104 M NADH and 0.002% tetradecanal solutions
were used. The assay was performed in 0.05 M phosphate buffer (pH
6.8) at room temperature.
Fullerenes were synthesized using carbon helium high-frequency arc
plasma at the atmospheric pressure (36,37). The fullerene content in car-
bon soot was about 12.6%. Fullerene mixture was extracted with toluene,
and the individual C60 fullerene was separated by liquid chromatography
with turbostratic graphite (interplanar distance 3.42 A) as a stationary
phase and toluene/hexane (4:6) mixture as a mobile phase.
Fullerenol C60O2–4(OH)20–24, F60, was produced by fullerene hydroxy-
lation in concentrated nitric acid followed by the hydrolysis of the
polynitrofullerenes (7,37,38). The Fe-containing fullerenol, F60Fe, was
produced from a powder mixture of Fe-containing fullerene soot and
acetylacetonate FeIII (Fe(acac)3). The mixture was heated up to sponta-
neous ignition at 180°C. The process was continued in the smoldering
regime with temperature increase up to ~ 250°C. Then, the product was
exposed to concentrated nitric acid at 90°C. The residuum was removed
by ﬁltration; red cinnamonic solution was evaporated and treated with
distilled water to provide for the hydrolysis of polynitrofullerene to poly-
hydroxylated fullerene. According to the elemental analysis, the average
empirical formula of the fullerenol is Fe0.5C60(OH)xOУ (x + y = 40–42).
The fullerenol preparations were characterized with IR and photoelec-
tron spectroscopies (39).
Experimental data processing. The effects of fullerenols on
bioluminescence of enzymatic assay system were evaluated by relative
bioluminescent intensity, IrelF :
IrelF ¼ IF=Icontr ð1Þ
Here, Icontr and IF are the maximal bioluminescent intensities in the
absence and presence of fullerenols, respectively. The values of IrelF < 1
revealed a toxic effect of fullerenols, while the values of IrelF 1 indicated
the absence of such. The effective concentrations of fullerenols that reduce
bioluminescent intensity by 50% (IrelF = 0.5), EC50-F, have been deter-
mined; they were used to evaluate and compare toxicities of the fullerenols.
SD values for IrelF did not exceed 0.05. The data for the I
rel
F calcula-
tions were obtained in three parallel experiments with ﬁve samplings for
all fullerenol and control solutions.
The effects of oxidizers on bioluminescence of enzyme assay system
were evaluated by a similar way, that is with relative bioluminescent
intensity, IrelOx:
IrelOx ¼ IOx=Icontr ð1aÞ
Here, Icontr and IOx are maximal bioluminescent intensities in the
absence and presence of oxidizers, respectively, Fig. 1.
The effective concentrations of the oxidizers, that reduce biolumines-
cent intensity by 50% IrelOx = 0.5), EC50-Ox, have been determined.
Scheme 1.9 Hypothetical structure of fullerenol C60(OH)x.
2 Nadezhda S. Kudryasheva et al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
To characterize the changes of GT under exposure to fullerenols, the
detoxiﬁcation coefﬁcients, DGT, were calculated as follows:
DGT ¼ IrelOx+F=IrelOx; ð2Þ
where IrelOx+F and I
rel
Ox are relative bioluminescent intensities in oxidizer
solutions at EC50-Ox, in the presence and absence of fullerenols, respec-
tively. The values of DGT have been determined at different fullerenol
concentrations.
To characterize the oxidative toxicity (OxT), bioluminescent delay per-
iod in oxidizer solutions, (T0.5)Ox, was analyzed, Fig. 1. Changes of OxT
under fullerenol exposure were characterized with detoxiﬁcation coefﬁ-
cients, DOxT:
DOxT ¼ ðT0:5ÞOx=ðT0:5ÞOx+F: ð3Þ
Here, (T0.5)Ox+F and (T0.5)Ox are bioluminescence delay periods in oxi-
dizer solutions in the presence and absence of fullerenols, respectively,
Fig. 1. The values of DOxT have been determined at different fullerenol
concentrations.
The values of DGT > 1 and DOxT > 1 revealed a decrease of GT and
OxT in oxidizer solutions under the exposure to fullerenols. The values
of DGT  1 and DOxT  1 revealed the absence of the fullerenol effects.
The values of SD for DGT and DOxT did not exceed 0.1. The data for
the calculations of DGT or DOxT were obtained in ﬁve parallel experi-
ments with 4–5 samplings for all fullerenol and control solutions.
RESULTS AND DISCUSSION
Toxicity of fullerenol solutions
Figure 2 presents the dependence of bioluminescent intensity
IrelF of the enzymatic assay system on the concentrations of
fullerenols. Values of EC50-F have been determined; they
appeared to be about 0.1 and 0.005 g L1 for F60 and F60Fe,
respectively. These values indicate a higher toxicity of F60Fe.
The reasons for the higher toxicity can be related to the presence
of iron atoms in the fullerenol structure and the reduction of full-
erenol p-system (3,4,7,8).
The result demonstrates that the bioluminescent enzyme sys-
tem is applicable for evaluating the toxicity of fullerenols of dif-
ferent structure.
Antioxidant activity of fullerenols
The bioluminescent intensity was measured in the solutions of
model oxidizers 1,4-benzoquinone and potassium ferricyanide in
the absence and presence of fullerenols F60 and F60Fe.
The values of EC50-Ox were preliminary calculated as 10
5
M
and 2105 M for 1,4-benzoquinone and potassium ferricyanide,
respectively. These concentrations were applied to monitor the
changes of GT under exposure to fullerenols and calculate DGT
values.
Lower concentrations of fullerenols which do not produce
toxic effects (<5∙103 g L1 for F60 and <10
3 g L1 for F60Fe,
Fig. 2) have been chosen to monitor toxicity of the solutions.
The concentrations of fullerenols varied as shown in Figs. 3 and
4. Detoxiﬁcation coefﬁcients DGT and DOxT have been calculated
according to Eqs. (2) and (3), respectively. The results are shown
in Figs. 3 and 4.
Figure 3 presents dependencies of detoxiﬁcation coefﬁcients
DGT and DOxT on fullerenol concentrations in the solutions of
Figure 1. Bioluminescence kinetics in solution of a model oxidizer (Ox)
and fullerenol (F).
Figure 2. Bioluminescent intensity IrelF of enzymatic assay system at
different concentrations of F60 and F60Fe.
Figure 3. Detoxiﬁcation coefﬁcients DGT (a) and DOxT (b) vs. concentra-
tion of fullerenols F60 and F60Fe in solutions of 1,4-benzoquinone
(105 M).
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the organic oxidizer, 1,4-benzoquinone. The antioxidant effect of
F60 (DGT > 1, DOxT > 1) in a wide range of fullerenol concen-
trations is evident from Fig. 3a, b, while fullerenol F60Fe does
not show a toxicity decrease as values of DGT and DOxT were
found to be close to 1 (Fig. 3a, b).
Figure 4 demonstrates the effects of the fullerenols in solu-
tions of inorganic oxidizer, potassium ferricyanide: The antioxi-
dant effect of F60 (DGT > 1, DOxT > 1) is evident from this
ﬁgure, while fullerenol F60Fe does not demonstrate a toxicity
decrease (the values of DGT and DOxT were close to 1). It is
noticeable that the detoxiﬁcation coefﬁcients in the solutions of
the inorganic oxidizer exposed to F60 (Fig. 4) appeared to be
lower than those in organic oxidizer solutions (Fig. 3).
In (40), a similar effect was explained through the involve-
ment of hydrophobic interactions in the detoxiﬁcation mecha-
nism. In that paper, the antioxidant properties of fullerenols were
ascribed to their catalytic activity in the enzymatic reactions.
Fullerenol’ antioxidant effect for bacterial cells is more complex;
it was discussed (40) in terms of hormesis phenomenon. In this
context, it should be stressed that antioxidant effects in vivo are
sometimes more intricate than in vitro. For instance, chain-break-
ing antioxidants may exhibit considerable activity in living
organisms despite their rather moderate radical-scavenging efﬁ-
ciency in model oxidation processes (41).
CONCLUSION
The study demonstrates a high potential of the bioluminescent
enzymatic assay for evaluating the toxicity and antioxidant activity
of bioactive compounds. The assay enables studying the toxic and
antioxidant effects at the level of nanosized structures (enzymes,
low-molecular components of enzymatic reactions and bioactive
compounds). The assay provides for the evaluation of both oxida-
tive toxicity (OxT) and GT. These toxicity types consider redox
processes (for OxT) and nonadditive integral combination of
redox-, hydrophobic- and polar-dependent interactions (for GT).
Two fullerenols of different structure were chosen here as
model bioactive species. The results show different antioxidant
efﬁciency and toxicity of these fullerenols, supporting, by this,
applicability of the assay.
The procedure steps for evaluating the antioxidant and toxic
effect of bioactive compounds are described below. Fullerenols
(F) are considered here as an example of bioactive compounds.
1 Registration of bioluminescent kinetics (Fig. 1) for enzyme
preparation (control-1); enzyme preparation + oxidizer (con-
trol-2); enzyme preparation + oxidizer + fullerenol (tested
sample). Evaluation of maximal bioluminescent intensities
Icontr, IOx and IOx+F, as well as induction periods in control-2
(T0.5)Ox and tested samples (T0.5)Ox+F, Fig. 1.
2 Calculation of IrelF , I
rel
Ox and I
rel
Ox+F using Eqs. (1) and (1a).
Statistical treatment.
3 Evaluation of effective concentrations of fullerenols, EC50-F.
Comparison of EC50-F of fullerenols. A conclusion on the dif-
ference in the toxicities of the fullerenols.
4 Calculation of DGT and DOxT according to Eqs. (2) and (3).
Statistical treatment. A conclusion on the antioxidant activity
of fullerenols: Values of DGT, DOxT > 1 indicate antioxidant
activity. A conclusion on the difference in the antioxidant
activity of the fullerenols.
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